1.Betty H . Kevles著,楊玉齡譯,露骨-醫學造影檔案,天下遠見出版股份有限公司,1999 p.49-56
2.王文竹,透視生物巨分子結構,科學月刊,2002,396:p.1033~10363.科學月刊 1981年10月142期
4.McMurry著,王健行等譯,有機化學 (全),高立圖書有限公司,p. 457-474
5.Gavaghan CL, Nicholson JK, Connor SC, Wilson ID, Wright B, Holmes E. Directly coupled high-performance liquid chromatography and nuclear magnetic resonance spectroscopic with chemometric studies on metabolic variation in Sprague--Dawley rats. Anal Biochem. 2001 15;291: 245-52.
6.Bollard ME, Holmes E, Lindon JC, Mitchell SC, Branstetter D, Zhang W, Nicholson JK. Investigations into biochemical changes due to diurnal variation and estrus cycle in female rats using high-resolution (1)H NMR spectroscopy of urine and pattern recognition. Anal Biochem. 2001;295: 194-202.
7.Gavaghan CL, Holmes E, Lenz E, Wilson ID, Nicholson JK. An NMR-based metabonomic approach to investigate the biochemical consequences of genetic strain differences: application to the C57BL10J and Alpk: ApfCD mouse. FEBS. 2000;484:169-74.
8.Gavaghan CL, Wilson ID, Nicholson JK. Physiological variation in metabolic phenotyping and functional genomic studies: use of orthogonal signal correction and PLS-DA.FEBS. 2002;530:191-6.
9.Brindle JT, Antti H, Holmes E, Tranter G, Nicholson JK, Bethell HW, Clarke S, Schofield PM, McKilligin E, Mosedale DE, Grainger DJ. Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics. Nat Med. 2002;8:1439-44.
10.Wevers RA, Engelke UF, Moolenaar SH, Brautigam C, de Jong JG, Duran R, de Abreu RA, van Gennip AH. 1H-NMR spectroscopy of body fluids: inborn errors of purine and pyrimidine metabolism. Clin Chem. 1999;45:539-48.
11.Messana I, Forni F, Ferrari F, Rossi C, Giardina B, Zuppi C. Proton nuclear magnetic resonance spectral profiles of urine in type II diabetic patients. Clin Chem. 1998;44:1529-34.
12.Hart BA, Vogels JT, Spijksma G, Brok HP, Polman C, van der Greef J. 1H-NMR spectroscopy combined with pattern recognition analysis reveals characteristic chemical patterns in urines of MS patients and non-human primates with MS-like disease. J Neurol Sci. 2003; 212:21-30.
13.Lenz EM, Bright J, Wilson ID, Morgan SR, Nash AF. 1H NMR-based metabonomic study of urine and plasma samples obtained from healthy human subjects. J Pharm Biomed Anal. 2003; 33:1103-15.
14.Zuppi C, Messana I, Forni F, Ferrari F, Rossi C, Giardina B, Zuppi C. Proton nuclear magnetic resonance spectral profiles of urine in type II diabetic patients. Clin Chem. 1998;44:1529-34
15.Nicholson JK, Lindon JC, Holmes E. ''Metabonomics'': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica. 1999;29:1181-9
16.Svensson BG, Akesson B, Nilsson A, Paulsson K. Urinary excretion of methylamines in men with varying intake of fish from the Baltic Sea. J Toxicol Environ Health. 1994;41:411-20..
17.Zuppi C, Messana I, Forni F, Ferrari F, Rossi C, Giardina B. Influence of feeding on metabolite excretion evidenced by urine 1H NMR spectral profiles: a comparison between subjects living in Rome and subjects living at arctic latitudes (Svaldbard).Clin Chim Acta. 1998;278:75-79.
18.Clifford MN, Copeland EL, Bloxsidge JP, Mitchell LA. Hippuric acid as a major excretion product associated with black tea consumption. Xenobiotica. 2000;30:317-26.
19.Clayton TA, Lindon JC, Everett JR, Charuel C, Hanton G, Le Net JL, Provost JP, Nicholson JK. A hypothesis for a mechanism underlying hepatotoxin-induced hypercreatinuria. Arch Toxicol. 2003;77:208-17.
20.Lenz EM, Bright J, Wilson ID, Hughes A, Morrisson J, Lindberg H, Lockton A. Metabonomics, dietary influences and cultural differences: a 1H NMR-based study of urine samples obtained from healthy British and Swedish subjects. J Pharm Biomed Anal. 2004;36:841-9
21.Zuppi C, Messana I, Forni F, Rossi C, Pennacchietti L, Ferrari F, Giardina B. 1H NMR spectra of normal urines: reference ranges of the major metabolites. Clin Chim Acta. 1997;265:85-97..
22.Zuppi C, Messana I, Tapanainen P, Knip M, Vincenzoni F, Giardina B, Nuutinen M. Proton Nuclear Magnetic Resonance Spectral Profiles of Urine from Children and Adolescents with Type 1 Diabetes. Clin Chem. 2002;48:660-2.
23.Ko¨rner A, Eklo¨f AC, Celsi G, Aperia A. Increased renal metabolism in diabetes. Mechanism and functional implications. Diabetes 1994;43:629–33.
24.Christiansen SJ, Gammelgaard J, Frandsen M, Parving HH. Increased kidney size, glomerular filtration rate and renal plasma flow in short-term insulin-dependent diabetes. Diabetologia 1981;20:451–6.
25.Hodgkinson A. Citric acid excretion in normal adults and in patients with renal calculus. Clin Sci 1962;23:203-5.
26.Nicholson JK, Timbrell JA, Sadler PJ. Proton NMR spectra as indicators of renal damage. Mercury induced nephrotoxicity in rats. Mol Pharmacol 1985;27:644–51.
27.Foxall PJD, Mellotte GJ, Bending MR, Lindon JC, Nicholson JK.NMR spectroscopy as a novel approach to the monitoring of renal transplant function. Kidney Int 1993;43:234-45.
28.Tessari P. Effects of insulin on whole-body and regional amino acid metabolism. Diabetes Metab Rev 1994;10:253–85.
29.Lundina TA, Knubovets TL, Sedov KR, Markova SA, Sibeldin LA .Variability of kidney tubular interstitial distorsions in glomerulonephritis as measured by 1H NMR urinalysis. Clin Chim Acta 1993;214:165–73.
30.Gartland KPR, Bonner FW, Nicholson JK. Investigation into the biochemical effects of region specific nephrotoxins. Mol Pharmacol 1989;35:242-250.1
31.Yaqoob M, Patrick AW, McClelland P, Stevenson A, Mason H, Whites MC, et al. Relationship between markers of endothelial dysfunction, oxidant injury and tubular damage in patients with insulin-dependent diabetes mellitus. Clin Sci 1993;85:557-562.
32.Yaqoob M, McClelland P, Patrick AW, Stevenson A, Mason H, Bell GM. Tubular damage in microalbuminuric patients with primary glomerulonephritis and diabetic nephropathy. Am J Nephrol 1990; 10:475-481.
33.Mogensen CE, Christensen CK, Vittinghus E. The stages in diabetic renal disease with emphasis on the stage of incipient diabetic nephropathy. Diabetes 1983;32(Suppl 2):64-78.
34.Bell JD, Lee JA, Sadler PJ, Wolkle DR, Woodhain RH. Nuclear magnetic resonance studies of blood plasma and urine from subjects with chronic renal failure: identification of trimethylamine-N-oxide. Biochem Biophys Acta 1991;1096:101-7.
35.Le Moyec L, Pruna A, Eugene M, Bedrossian J, Idatte JM, Huneau JF, Tome D. Proton nuclear magnetic resonance spectroscopy of urine and plasma in renal transplantation follow-up. Nephron 1993;65:433-9.
36.Anthony ML, Gartland KPR, Beddell CR, Lindon JC, Nicholson JK. Cephaloridine-induced nephrotoxicity in the Fischer 344 rat: proton NMR spectroscope studies of urine and plasma in relation to conventional clinical chemical and histopathological assessments of nephronal damage. Arch Toxicol 1992;66:52.
37.Walsh MC, Brennan L, Malthouse JP, Roche HM, Gibney MJ. Effect of acute dietary standardization on the urinary, plasma, and salivary metabolomic profiles of healthy humans. Am J Clin Nutr. 2006; 84:531-9.
38.Nicholson JK, Connelly J, Lindon JC, Holmes E. Metabonomics: a platform for studying drug toxicity and gene function. Nat Rev Drug Discov. 2002;1:153-61.
39.Keun HC. Metabonomic modeling of drug toxicity. Pharmacol Ther. 2006;109:92-106.
40.Robertson DG. Metabonomics in toxicology: a review. Toxicol Sci. 2005;85:809-22.
41.Brindle JT, Antti H, Holmes E, Tranter G, Nicholson JK, Bethell HW, Clarke S, Schofield PM, McKilligin E, Mosedale DE, Grainger DJ. Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics. Nat Med. 2002;8:1439-44.
42.Brindle JT, Nicholson JK, Schofield PM, Grainger DJ, Holmes E. Application of chemometrics to 1H NMR spectroscopic data to investigate a relationship between human serum metabolic profiles and hypertension. Analyst. 2003;128:32-6.
43.''t Hart BA, Vogels JT, Spijksma G, Brok HP, Polman C, van der Greef J.1H-NMR spectroscopy combined with pattern recognition analysis reveals characteristic chemical patterns in urines of MS patients and non-human primates with MS-like disease. J Neurol Sci. 2003 15;212:21-30.
44.Odunsi K, Wollman RM, Ambrosone CB, Detection of epithelial ovarian cancer using 1H-NMR-based metabonomics. Int J Cancer 2005;113:782-8.